DCC and Parkinson disease: In the present study, we first examined changes in the NTN‐1/DCC pathway in multiple animal models of PD and altered NTN‐1/DCC signaling in SH‐SY5Y cells after exposure to 1‐Methyl‐4‐phenyl pyridinium iodide (MPP+).